AVGO vs CRH Stock Comparison

Compare AVGO and CRH across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.

Market data as of Sep 6, 2026 market close· AIQ score gap 1 points
AVGO
Technology
vs
CRH
Basic Materials
AVGO
Broadcom Inc.
Price
$358
Day move
+0.21%
AIQ Score
47/100
Best edge
Quality
Sector
Technology
CRH
CRH plc
Leads
Price
$94.26
Day move
+2.41%
AIQ Score
48/100
Best edge
Momentum
Sector
Basic Materials

What is the main difference between AVGO and CRH?

CRH leads the current stock comparison as CRH plc, with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Broadcom Inc. vs CRH plc

Data as of Sep 6, 2026· market close· Cross-sector · Technology vs Basic Materials· Coverage 66/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 3/10

CRH leads

CRH leads by 1 AIQ points, primarily on Momentum and Value, having only recently taken the lead back from AVGO.

Fragile: 3 of 6 evidence groups support CRH, and the lead recently changed hands.

Evidence agreement: 3 of 6Comparison trend: Reversed
AVGO

Broadcom Inc.

AIQ Score
47/100
AIQ Edge Score
4/10
CRH

CRH plc

Leads
AIQ Score
48/100
AIQ Edge Score
4/10

The Algovestiq AIQ Score currently favors CRH over AVGO, 48 versus 47 as of Sep 6, 2026. CRH's advantage is driven primarily by stronger momentum and value, while AVGO holds the stronger quality profile. CRH also shows the stronger technical structure relative to its 50-day moving average. 3 of 6 covered evidence groups favor CRH today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. CRH lead: Reversed — AVGO led by 12 AIQ points 30 sessions ago; CRH now leads by 1.

Compare Broadcom Inc. and CRH plc across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Performance over time

Price-return comparison using available daily close history.

AVGO
+623.9%
CRH
+83.3%

Total return comparison

Growth of $10,000

AVGO $72,393 · CRH $18,331

Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.

Compare AVGO and CRH against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

AVGO advantage
0
CRH advantage
  • Quality30%85 vs 58
    AVGO +27
  • Momentum25%20 vs 38
    CRH +18
  • Value30%30 vs 41
    CRH +11
  • Risk Resilience15%53 vs 59
    CRH +6

3 of 6 evidence groups favor CRH. CRH’s edge is concentrated in momentum and value; AVGO keeps a meaningful quality edge.

What changed since the last close

Latest scored session 2026-09-05, compared against the prior scored session 2026-09-04.

AVGO0 AIQ

No factor moved materially.

No new signals fired.

CRH0 AIQ

No factor moved materially.

No new signals fired.

CRH's lead was unchanged in the latest snapshot.

Deeper signal detail for each name lives on its own signals page — AVGO and CRH both carry a full feed there.

The central trade-off

CRH (CRH plc): the stronger current systematic profile, led by momentum and value.

AVGO (Broadcom Inc.): the counter-case, on quality, fundamentals, technicals — but at materially higher volatility, 35.2% against 27.2%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

CRH

CRH on the overall AIQ Score, which weights Quality and Value at 30% each.

Growth

CRH

CRH on combined revenue and EPS growth.

Value

CRH

CRH on the peer-relative Value factor, by 11 points.

Momentum

CRH

CRH on the Momentum factor, by 18 points.

Lower downside

CRH

CRH on Risk Resilience, by 6 points.

Analyst upside

CRH

CRH on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureAVGOCRHNote
Implied upside to target+41%+48.2%CRH has more room
Target dispersion+49.5%+29.1%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering175Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor CRH. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven47 vs 48
FundamentalsAVGOon balancerevenue growth 14.9% vs 46.2%; EPS growth 26.5% vs 9.2%; TTM ROE 36.4% vs 23.8%; gross margin 67% vs 35.8%; operating margin 43.7% vs 13.5% — AVGO takes 4 of 5 decided legs, not all of them
ValuationCRHValue 30 vs 41
TechnicalsAVGOPrice vs 50-day -6.7% vs -5.5%; vs 200-day -3.2% vs -15.4%
Risk ResilienceCRHRisk Resilience 53 vs 59
Analyst expectationsCRHTarget upside 41% vs 48.2%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and CRH and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • Signal direction runs against the verdict: the leader is net-bearish while the laggard is net-bullish. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CRH.

How the comparison changed

120 daily snapshots · Apr 24 Sep 5

CRH lead: Reversed — AVGO led by 12 AIQ points 30 sessions ago; CRH now leads by 1.

Apr 24AVGO leads above the line · CRH leads belowSep 5
Today
CRH +1
47 vs 48
7 sessions ago
AVGO +2
47 vs 45
30 sessions ago
AVGO +12
58 vs 46
90 sessions ago
CRH +2
47 vs 49

The lead changed hands 6 times in this window, most recently on Sep 4 when CRH moved ahead of AVGO.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

AVGOConflicted

2 bullish / 1 bearish / 1 neutral, conflicted

  • Golden Cross Active bullish, trend, long horizon (3.74%)
  • RSI Oversold - Potential Bounce bullish, momentum, short horizon
  • ATR Expansion - Breakout Mode neutral, volatility, short horizon (3.64%)
CRH

0 bullish / 4 bearish

  • Death Cross Active bearish, trend, long horizon (11.75%)
  • 52-Week Low Proximity bearish, risk, long horizon (1.5%)
  • Downtrend Structure Active bearish, trend, long horizon

AVGO is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

AVGONo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.21%, AIQ 0 points).

CRHNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +2.41%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1AVGO closes the Momentum gap — currently 18 points behind, the largest single contributor to CRH's edge.
  2. 2AVGO's ATR Expansion - Breakout Mode turns directional — it is neutral today and would confirm a change in trend.
  3. 3CRH starts generating bearish momentum or trend signals.
  4. 4A regime shift changes factor weighting — the composite weights Quality and Value at 30% each, so a rotation toward either would move the result most.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

AVGO leads on balance
MetricAVGOCRH
Revenue growth (YoY)14.9%46.2%
EPS growth (YoY)26.5%9.2%
Gross margin67%35.8%
Operating margin43.7%13.5%
Return on equity (TTM)36.4%23.8%
Debt to equity0.740.82

Performance

AVGO leads 4 of 6 windows
MetricAVGOCRH
1 week (5 sessions)-3%-1.7%
1 month (20 sessions)-16.3%-6.2%
3 months (63 sessions)-7.2%-10.3%
6 months (126 sessions)8.3%-11.4%
Year to date3.4%-24.5%
1 year (252 sessions)18.4%-15.8%

Technicals

AVGO has the stronger structure
MetricAVGOCRH
RSI (14)29.245.7
ADX (14)23.727.4
Price vs 50-day-6.7%-5.5%
Price vs 200-day-3.2%-15.4%
Volatility (1M, annualized)35.2%27.2%

Risk

CRH is the more resilient
MetricAVGOCRH
Beta2.151.28
Sharpe ratio0.48-0.49
Sortino ratio0.73-0.87
Max drawdown-28.9%-30.6%
Current drawdown-25.7%-28.3%
Annualized volatility48.4%32%
Value at risk (95%)-4.4%-3.3%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, AVGO or CRH?

On the Algovestiq AIQ Score, CRH is the stronger of the two as of Sep 6, 2026, scoring 48 against AVGO's 47. The edge comes from momentum and value. AVGO is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is AVGO or CRH the better buy right now?

CRH carries the stronger systematic profile as of Sep 6, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.

Why does the AIQ Score favor CRH over AVGO?

The composite weights Quality at 30%, Value at 30%, Momentum at 25% and Risk Resilience at 15%. AVGO leads Quality by 27 points; CRH leads Momentum by 18 points; CRH leads Value by 11 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, AVGO or CRH?

Analyst price targets imply +41% upside for AVGO and +48.2% for CRH, so the Street currently favors CRH. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, AVGO or CRH?

CRH is the better-valued of the two on the peer-relative Value factor. CRH on the peer-relative Value factor, by 11 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, AVGO or CRH?

CRH on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, AVGO or CRH?

CRH on the Momentum factor, by 18 points. Momentum carries 25% of the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, AVGO or CRH?

CRH is the more resilient of the two, so the other name carries the higher downside risk. CRH on Risk Resilience, by 6 points. The Risk Resilience factor weights 15% of the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is AVGO more profitable than CRH?

AVGO leads on the comparable margin measures — gross margin 67% vs 35.8%; operating margin 43.7% vs 13.5%; ttm roe 36.4% vs 23.8%.

Is CRH's lead over AVGO getting stronger or weaker?

CRH lead: Reversed — AVGO led by 12 AIQ points 30 sessions ago; CRH now leads by 1. This is measured from 120 daily comparison snapshots between 2026-04-24 and 2026-09-05. The lead has changed hands 6 times in that window, most recently on 2026-09-04, when CRH moved ahead of AVGO.

What would change the AVGO vs CRH verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVGO closes the Momentum gap — currently 18 points behind, the largest single contributor to CRH's edge; AVGO's ATR Expansion - Breakout Mode turns directional — it is neutral today and would confirm a change in trend; CRH starts generating bearish momentum or trend signals; a regime shift changes factor weighting — the composite weights Quality and Value at 30% each, so a rotation toward either would move the result most.

What do the current signals say about AVGO and CRH?

AVGO: 2 bullish / 1 bearish / 1 neutral, conflicted. CRH: 0 bullish / 4 bearish. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVGO is Golden Cross Active (bullish, long horizon). On CRH it is Death Cross Active (bearish, long horizon).

Compare AVGO and CRH with others

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality (30%), Value (30%), Momentum (25%) and Risk (15%). Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.